Pensionfund Sabic Bristol Myers Squibb CO Transaction History

Pensionfund Sabic

$320 Million
Q3 2024

A detailed history of Pensionfund Sabic transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pensionfund Sabic holds 30,500 shares of BMY stock, worth $1.81 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

30,500

Previous 33,000 7.58%

Holding current value

$1.81 Million

Previous $1.37 Million 15.18%

% of portfolio

0.49%

Previous 0.4%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$39.66 - $51.75 $99,149 - $129,375	-2,500 Reduced 7.58%	30,500 $1.58 Million
Q1 2024 Apr 08, 2024	SELL	$47.98 - $54.4 $47,980 - $54,400	-1,000 Reduced 2.94%	33,000 $1.79 Million
Q4 2023 Jan 04, 2024	BUY	$48.48 - $57.85 $96,960 - $115,700	2,000 Added 6.25%	34,000 $1.75 Million
Q1 2023 Apr 03, 2023	SELL	$65.71 - $74.53 $262,840 - $298,120	-4,000 Reduced 11.11%	32,000 $2.22 Million
Q2 2022 Jul 06, 2022	SELL	$72.62 - $79.98 $363,100 - $399,900	-5,000 Reduced 12.2%	36,000 $2.77 Million
Q1 2022 Apr 12, 2022	SELL	$61.48 - $73.72 $676,280 - $810,920	-11,000 Reduced 21.15%	41,000 $2.99 Million
Q1 2021 Apr 01, 2021	SELL	$59.34 - $66.74 $356,040 - $400,439	-6,000 Reduced 10.34%	52,000 $3.28 Million
Q3 2020 Oct 05, 2020	BUY	$57.43 - $63.64 $172,290 - $190,920	3,000 Added 5.45%	58,000 $3.5 Million
Q4 2019 Jan 06, 2020	BUY	$49.21 - $64.19 $393,680 - $513,520	8,000 Added 17.02%	55,000 $3.53 Million
Q3 2018 Oct 01, 2018	BUY	$55.19 - $62.25 $2.59 Million - $2.93 Million	47,000 New	47,000 $2.92 Million
Q1 2018 Apr 03, 2018	SELL	$59.92 - $68.98 $2.46 Million - $2.83 Million	-41,000 Closed	0 $0
Q4 2017 Jan 02, 2018	BUY	$59.94 - $65.35 $2.46 Million - $2.68 Million	41,000	41,000 $2.51 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionfund Sabic, based on Form 13F filings with the SEC.

News

Stay updated on Pensionfund Sabic with notifications on news.

Account

Pensionfund Sabic Bristol Myers Squibb CO Transaction History